<DOC>
<DOCNO>
EP-0003455
</DOCNO>
<TEXT>
<DATE>
19790808
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/58 A61P-9/04 C07J-41/00 A61K-31/585 A61P-9/00 A61K-31/785 <main>C07J-41/00</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
3-amino-cardenolides, process for their preparation and medicines containing them.
</TITLE>
<APPLICANT>
nativelle sa etsfr   <sep>etablissements nativelle s.a.<sep>etablissements nativelle s.a.27, rue de la processionf-75015 parisfr<sep>etablissements nativelle s.a. <sep>
</APPLICANT>
<INVENTOR>
jarreau francois-xavier<sep>koenig jean-jacques<sep>jarreau, francois-xavier<sep>koenig, jean-jacques<sep>jarreau, françois-xavier5, rue louis hervéf-78000 versaillesfr<sep>koenig, jean-jacques1, rue rodinf-91380 chilly-mazarinfr<sep>jarreau, francois-xavier<sep>koenig, jean-jacques  <sep>jarreau, françois-xavier5, rue louis hervéf-78000 versaillesfr<sep>koenig, jean-jacques1, rue rodinf-91380 chilly-mazarinfr<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to novel aminocardenolide derivatives and a reaction preparation method of an oxo-3-gengin with an ammonium salt in the presence of a borocyanohydride in an organic solvent, to form the compounds of formula: wherein R₁, R₂, R₄, R₅, and R₆, identical or different, represent a hydrogen atom or a hydroxy, alkoxy or acyloxy group;R₃ represents a lower alkyl, hydroxyalkyl, acyloxyalkyl, haloalkyl, or ethylene dioxyalkyl;R₇ represents a hydrogen atom, an alkyl or acyl group;R₈ represents a hydrogen atom or an achyl group, or a remaining amino acid.Application to preparation of drugs, especially for the treatment of cardiac conditions.
</ABSTRACT>
</TEXT>
</DOC>
